Last updated: May 29, 2026

Application No. 17/709,136

NEURAL ORGANOID COMPOSITION AND METHODS OF USE

Final Rejection

Filed

Mar 30, 2022

Priority

Jan 14, 2016 — provisional 62/278,857 +3 more

Examiner

MOLOYE, TITILAYO

Art Unit

1632

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Rene Anand

OA Round

2 (Final)

This examiner grants 63% of cases after interview

— +47.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 533 resolved cases, 2023–2026

Examiner Intelligence

MOLOYE, TITILAYO View full profile →

Grants 63% of resolved cases

Career Allowance Rate

338 granted / 533 resolved

+3.4% vs TC avg

Strong +47% interview lift

Without

With

+47.1%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

42 currently pending

Career history

581

Total Applications

across all art units

Statute-Specific Performance

§101

1.6%

-38.4% vs TC avg

§103

56.9%

+16.9% vs TC avg

§102

5.8%

-34.2% vs TC avg

§112

19.7%

-20.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 533 resolved cases

Prosecution Timeline

Mar 30, 2022

Application Filed

May 19, 2025

Non-Final Rejection mailed

Nov 17, 2025

Response Filed

Dec 09, 2025

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/321,792

Patent 12630804

BLOOD BRAIN BARRIER MODEL

7y 3m to grant Granted May 19, 2026

17/340,434

Patent 12619211

METHOD AND APPARATUS FOR A TISSUE ENGINEERING SYSTEM UTILIZING STACKED LAYERS

4y 11m to grant Granted May 05, 2026

17/469,578

Patent 12618054

CRISPR/CPF1 SYSTEMS AND METHODS

4y 8m to grant Granted May 05, 2026

17/298,367

Patent 12611430

THERAPEUTIC AGENT OF PERIPHERAL BLOOD FLOW DISORDER

4y 11m to grant Granted Apr 28, 2026

17/471,776

Patent 12606834

METHODS AND COMPOSITIONS FOR EFFICIENT DELIVERY OF NUCLEIC ACIDS AND RNA-BASED ANTIMICROBIALS

4y 7m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

63%

Grant Probability

99%

With Interview (+47.1%)

3y 7m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 533 resolved cases by this examiner. Grant probability derived from career allowance rate.